Evaluation and treatment of superficial esophageal cancer

Journal of Gastrointestinal Surgery

Volumn 14, Issue SUPPL.1, 2010, Pages

  DeMeester, Steven R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adenocarcinoma of the esophagus; Barrett's esophagus; Chronic gastroesophageal reflux disease; Dysplasia; Endoscopic resection; Superficial esophageal cancer

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER INVASION; CANCER STAGING; ESOPHAGOSCOPY; ESOPHAGUS; ESOPHAGUS TUMOR; GASTROESOPHAGEAL REFLUX; HUMAN; PATHOLOGY; QUALITY OF LIFE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; QUALITY OF LIFE;

EID: 77951252453     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1025-1     Document Type: Article

References (42)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97(2): 142-146.
2. Brown LM, Devesa SS, Chow W-H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100(16): 1184-1187.
3. Crane LMA, Schaapveld M, Visser O, et al. Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival. Eur J Cancer 2007; 43(9): 1445-1451.
4. Oh DS, Hagen JA, Chandrasoma PT, et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg 2006; 203(2): 152-161.
5. Rice TW, Blackstone EH, Goldblum JR, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001; 122(6): 1077-1090.
6. Stein HJ, Feith M, Bruecher BL, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005; 242(4): 566-573. discussion 573-5.
7. Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999; 230(3): 433-440.
8. May A, Gunter E, Roth F, et al. Accuracy of staging in early esophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004; 53: 634-640.
9. Maish MS, DeMeester SR. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 2004; 78: 1777-1782.
10. Tada M, Inoue H, Yabata E, et al. Colonic mucosal resection using a transparent cap-fitted endoscope.[see comment]. Gastrointest Endosc 1996; 44(1): 63-65.
11. Prasad GA, Buttar NS, Wongkeesong LM, et al. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol 2007; 102(11): 2380-2386.
12. Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008; 57(9): 1200-1206.
13. Schembre DB, Huang JL, Lin OS, et al. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.[see comment]. Gastrointest Endosc 2008; 67(4): 595-601.
14. Liu LMDP, Hofstetter WLMD, Rashid AMDP, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 2005; 29: 1079-1085.
15. Peyre C, DeMeester SR, Rizzetto C, et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett's with high-grade dysplasia. Ann Surg 2007; 246: 665-674.
16. Rice TW, Zuccaro G Jr, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998; 65(3): 787-792.
17. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy [see comments]. J Thorac Cardiovasc Surg 1999; 117(1): 16-23. discussion 23-5.
18. Ell C, May A, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).[see comment]. Gastrointest Endosc 2007; 65(1): 3-10.
19. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118(4): 670-677.
20. Buttar N, Nijhawan P, Krishnadath K, et al. Combined endoscopic mucosal resection (EMR) and photodynamic therapy (PDT) for esophageal neoplasia within Barrett's esophagus. Gastroenterology 2000; 118: A405.
21. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients.[see comment]. Gastrointest Endosc 2007; 65(2): 185-195.
22. Lang L. Radiofrequency ablation is effective treatment for dysplasia in Barrett's esophagus. Gastroenterology 2008; 135(1): 6.
23. Hernandez JC, Reicher S, Chung D, et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 2008; 40(5): 388-392.
24. Manner H, May A, Pech O, et al. Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008; 103(10): 2589-2597.
25. Tamhankar AP, Peters JH, Portale G, et al. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 2004; 8(7): 890-897. discussion 897-8.
26. Katz PO. Review article: the role of non-acid reflux in gastro-oesophageal reflux disease. Aliment Pharmacol & Ther 2000; 14(12): 1539-1551.
27. Lord RV, Wickramasinghe K, Johansson JJ, et al. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features. Surgery 2004; 136(3): 633-640.
28. Oberg S, Johansson J, Wenner J, Walther B. Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 2002; 235: 338-345.
29. Krishnadath KK, Wang KK, Taniguchi K, et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000; 119(3): 624-630.
30. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.[see comment]. Gastrointest Endosc 2003; 58(2): 183-188.
31. Prasad GA, Wang KK, Halling KC, et al. Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus. Cancer 2008; 113(3): 470-476.
32. Overholt BF, Wang KK, Burdick JS, et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.[see comment]. Gastrointest Endosc 2007; 66(3): 460-468.
33. Orringer MB, Marshall B, Chang AC, et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 2007; 246(3): 363-372. discussion 372-4.
34. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Esophageal stripping with preservation of the vagus nerve. Int Surg 1982; 67(2): 125-128.
35. Banki F, Mason RJ, DeMeester SR, et al. Vagal-sparing esophagectomy: a more physiologic alternative. Ann Surg 2002; 236(3): 324-335. discussion 335-6.
36. Peyre CG, DeMeester SR, Rizzetto C, et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia. Ann Surg 2007; 246(4): 665-671. discussion 671-4.
37. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405(6785): 458-462.
38. van Westerloo DJ, Giebelen IAJ, Florquin S, et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005; 191(12): 2138-2148.
39. Luyer MD, Greve JWM, Hadfoune Mh, et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005; 202(8): 1023-1029.
40. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997; 114(5): 824-829.
41. Headrick JR, Nichols FC 3rd, Miller DL, et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy.[see comment]. Ann Thorac Surg 2002; 73(6): 1697-1702. discussion 1702-3.
42. Williams VA, Watson TJ, Herbella FA, et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 2007; 11(12): 1589-1597.